Cargando…
Aiming drug discovery at lysophosphatidic acid targets
Lysophosphatidic acid (LPA, 1-radyl-2-hydroxy-sn-glycero-3-phosphate) is the prototype member of a family of lipid mediators and second messengers. LPA and its naturally occurring analogues interact with G protein-coupled receptors on the cell surface and a nuclear hormone receptor within the cell....
Autor principal: | Tigyi, Gabor |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989581/ https://www.ncbi.nlm.nih.gov/pubmed/20735414 http://dx.doi.org/10.1111/j.1476-5381.2010.00815.x |
Ejemplares similares
-
Regulation of Tumor Immunity by Lysophosphatidic Acid
por: Lee, Sue Chin, et al.
Publicado: (2020) -
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
por: Tigyi, Gábor, et al.
Publicado: (2021) -
Lysophosphatidic acid induces proliferation and osteogenic differentiation of human dental pulp stem cell through lysophosphatidic acid receptor 3/extracellular signal-regulated kinase signaling axis
por: Heo, Soon Chul, et al.
Publicado: (2023) -
Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016) -
Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation
por: Zhang, Chunxiang, et al.
Publicado: (2004)